Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CCLG Observational Study of the Outcome of Ependymoma in Infants Diagnosed Before Their Third Birthday

NCT00683319 is registered in ClinicalTrials.gov with Children's Cancer and Leukaemia Group as lead sponsor.

NCT NCT00683319
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00683319 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CCLG Observational Study of the Outcome of Ependymoma in Infants Diagnosed Before Their Third Birthday
Lead sponsor
Children's Cancer and Leukaemia Group
Phase
Observational
Overall status
Active, not recruiting
Start date
April 30, 2008
Completion date
Not reported
Enrollment
50 (estimated)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

brain and central nervous system tumors, cognitive/functional effects, long-term effects secondary to cancer therapy in children, ototoxicity